"Exploring the Future of Cancer Treatment: The Rise of Antibody Drug Conjugates (ADCs)"
The Antibody Drug Conjugates Market size was valued at USD 9.8 Billion in 2023 and the total Antibody Drug Conjugates revenue is expected to grow at a CAGR of 15.4% from 2024 to 2030, reaching nearly USD 22.5 Billion by 2030.
Antibody Drug Conjugates Market Overview
The report gives...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek